Follow
Immunotherapy
Immunotherapy: is a type of cancer treatment the helps the immune system to fight cancer. The immune system helps your body fight infections and other diseases. It uses substances made by the body or in a laboratory in order to improve or restore the body's immune system function.
What's Popular in Immunotherapy
-
SEP 05, 2025Cell & Molecular Biology
Our diets can affect our health, but despite extensive research, we still don’t have a great understanding ...Written By: Carmen LeitchMAY 19, 2025Cell & Molecular Biology
Pancreatic cancer is deadly; only about 10% of patents live over five years after they are diagnosed. Patients are typic ...Written By: Carmen LeitchOCT 21, 2024Microbiology
The link between cancer and bacteria that live in the human body has been known for a very long time. In the 19th centur ...Written By: Carmen LeitchJUN 11, 2024Drug Discovery & Development
Researchers used ultrasound to enable the delivery of a novel immunotherapy combination therapy for glioblastoma across ...Written By: Annie LennonAPR 15, 2024Microbiology
We share our world, and our bodies with microbes. The trillions of microorganisms in our guts have very clone connection ...Written By: Carmen Leitch
SEP 05, 2025
Cell & Molecular Biology
Our diets can affect our health, but despite extensive research, we still don’t have a great understanding ...
Written By:
Carmen Leitch
MAY 19, 2025
Cell & Molecular Biology
Pancreatic cancer is deadly; only about 10% of patents live over five years after they are diagnosed. Patients are typic
...
Written By:
Carmen Leitch
OCT 21, 2024
Microbiology
The link between cancer and bacteria that live in the human body has been known for a very long time. In the 19th centur
...
Written By:
Carmen Leitch
JUN 11, 2024
Drug Discovery & Development
Researchers used ultrasound to enable the delivery of a novel immunotherapy combination therapy for glioblastoma across
...
Written By:
Annie Lennon
APR 15, 2024
Microbiology
We share our world, and our bodies with microbes. The trillions of microorganisms in our guts have very clone connection
...
Written By:
Carmen Leitch
FEB 29, 2024
Immunology
Myeloid cells are a population of cells classified to denote a specific lineage. “Myeloid” specifically refe
...
Written By:
Brian G. Morreale
FEB 22, 2024
Immunology
The US Food and Drug Administration (FDA) recently approved a tumor-infiltrating lymphocyte (TIL) therapy referred to as
...
Written By:
Brian G. Morreale
FEB 21, 2024
Cancer
Last August, Labroots covered the decision of the National Health Service of England (NHS England) to allow subcu
...
Written By:
Katie Kokolus
FEB 15, 2024
Immunology
There are various ways to treat cancer. The gold standard has been chemotherapy for over 50-years. However, treatment wi
...
Written By:
Brian G. Morreale
-
MAR 26, 2024 | 7:00 PMC.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...Speaker: Steven Melnick. Ph.D., M.D. , Dr. David Mancuso, Pharm.D. CPh , MSPMSponsored By: Thermo Fisher ScientificMAR 26, 2024 | 8:00 AMC.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...Speaker: Steven Melnick. Ph.D., M.D. , Dr. David Mancuso, Pharm.D. CPh , MSPMSponsored By: Thermo Fisher ScientificFEB 15, 2024 | 8:00 AM
Macrophages can mediate phagocytosis of cancer cells and cytotoxic tumor killing, and engage in effective bidirectional interactions with components of the innate and adaptive immune system....DEC 05, 2023 | 8:00 AM
CGX10 Cell Isolation System: Introduction, Utility, and Assessment in a GMP-grade Environment for Multiparametric Cell Sorting A future of long-term, minimally toxic immunotherapy personaliz...NOV 07, 2023 | 10:00 AM
In the last 5 years, the US Food and Drug Administration has approved 4 anti-CD19 chimeric antigen receptor T cell (CART19) products for relapsed/refractory B cell lymphomas and leukemia. Ho...
MAR 26, 2024 | 7:00 PM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
Speaker:
Steven Melnick. Ph.D., M.D.
, Dr. David Mancuso, Pharm.D. CPh , MSPM
Sponsored By: Thermo Fisher Scientific
MAR 26, 2024 | 8:00 AM
C.E. CREDITS
The implementation of a preemptive pharmacogenomics (PGx) program in a hospital setting requires a multidisciplinary approach to ensure seamless integration of each stage of the process for...
Speaker:
Steven Melnick. Ph.D., M.D.
, Dr. David Mancuso, Pharm.D. CPh , MSPM
Sponsored By: Thermo Fisher Scientific
FEB 15, 2024 | 8:00 AM
Macrophages can mediate phagocytosis of cancer cells and cytotoxic tumor killing, and engage in effective bidirectional interactions with components of the innate and adaptive immune system....
DEC 05, 2023 | 8:00 AM
CGX10 Cell Isolation System: Introduction, Utility, and Assessment in a GMP-grade Environment for Multiparametric Cell Sorting A future of long-term, minimally toxic immunotherapy personaliz...
NOV 07, 2023 | 10:00 AM
In the last 5 years, the US Food and Drug Administration has approved 4 anti-CD19 chimeric antigen receptor T cell (CART19) products for relapsed/refractory B cell lymphomas and leukemia. Ho...
NOV 01, 2023 | 8:00 AM
To bring your cutting-edge cell and gene therapies to the patients that need them as quickly as possible, you need access to the most knowledgeable scientists, innovative technologies, metho...
OCT 25, 2023 | 8:30 PM
The CytPix is a flow cytometer that can simultaneously collect fluorescence data and high-resolution brightfield images of individual cells. This allows to better understand the morphology o...
OCT 25, 2023 | 8:00 AM
The CytPix is a flow cytometer that can simultaneously collect fluorescence data and high-resolution brightfield images of individual cells. This allows to better understand the morphology o...
OCT 12, 2023 | 8:00 AM
Patient-derived tumoroids, also known as cancer organoids, hold potential as cost-effective models for cancer immunotherapy research. Patient-derived tumor models, which mimic the tumor micr...
-
Labroots is pleased to announce the 5 th annual event in the Immuno-Oncology Virtual Event Series taking place on April 29th, 2026. Immuno-Oncology is at the forefront of groundbreaking rese...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...OCT 01, 2025 | 5:30 AM PDTC.E. CREDITS
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...APR 30, 2025 | 5:30 AM PDTC.E. CREDITS
Labroots is pleased to announce the 4th annual event in the Immuno-Oncology Virtual Event Series taking place on April 30th, 2025. Immuno-Oncology is at the forefront of groundbreaking resea...OCT 02, 2024 | 7:00 AM PDTC.E. CREDITS
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
Labroots is pleased to announce the 5 th annual event in the Immuno-Oncology Virtual Event Series taking place on April 29th, 2026. Immuno-Oncology is at the forefront of groundbreaking rese...
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
OCT 01, 2025
| 5:30 AM PDT
C.E. CREDITS
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
APR 30, 2025
| 5:30 AM PDT
C.E. CREDITS
Labroots is pleased to announce the 4th annual event in the Immuno-Oncology Virtual Event Series taking place on April 30th, 2025. Immuno-Oncology is at the forefront of groundbreaking resea...
OCT 02, 2024
| 7:00 AM PDT
C.E. CREDITS
Labroots is excited to bring leading academia and industry experts, research scholars, healthcare and medical professionals, clinicians, oncologists, and top scientists under one virtual roo...
APR 30, 2024
| 5:00 AM PDT
C.E. CREDITS
LabRoots is pleased to announce the inauguration of the Immuno-Oncology Virtual Event taking place on May 1, 2024. Immuno-Oncology is considered by some to be one of the most promising area...
MAR 19, 2024
| 7:00 PM PDT
With the FDA expecting to approve 10–20 cell and gene therapies (CGT) per year by 2025, it is evident that the field will continue to hold immense commercial and medical opportunities....
FEB 29, 2024
| 12:00 PM PST
C.E. CREDITS
Precision medicine in solid tumors is transforming the testing and treatment of cancer. You can be part of this exciting field by joining our one-day virtual event. Some of the highlights of...
OCT 03, 2023
| 5:30 AM PDT
Labroots is pleased to announce the 11th Annual Event in the Cancer Research & Immuno-Oncology Week Virtual Event Series! This 3 day event will take place on October 3-5, 2023....